NSC |
Compound |
Enrichment |
Correlation |
NSC 710895 |
3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide |
0.0435808621943462 |
0.28554578 |
NSC 716032 |
Null |
0.0435808621943462 |
0.35670851 |
NSC 71669 |
Null |
0.0435808621943462 |
0.16842419 |
NSC 722867 |
Null |
0.0435808621943462 |
0.25049777 |
NSC 723548 |
Null |
0.0435808621943462 |
0.38053918 |
NSC 723732 |
8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one |
0.0435808621943462 |
0.38658643 |
NSC 727087 |
16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate |
0.0435808621943462 |
0.11343481 |
NSC 728038 |
2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline |
0.0435808621943462 |
0.38751605 |
NSC 737757 |
2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole |
0.0435808621943462 |
0.29359388 |
NSC 740 |
Methotrexate |
0.0435808621943462 |
0.32241684 |